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PERSPECTIVE
Double Burden of Noncommunicable
and Infectious Diseases in
Developing Countries
I. C. Bygbjerg
On top of the unfinished agenda of infectious diseases in low- and middle-income countries,
development, industrialization, urbanization, investment, and aging are drivers of an epidemic of
noncommunicable diseases (NCDs). Malnutrition and infection in early life increase the risk of chronic
NCDs in later life, and in adult life, combinations of major NCDs and infections, such as diabetes
and tuberculosis, can interact adversely. Because intervention against either health problem will affect
the other, intervening jointly against noncommunicable and infectious diseases, rather than competing
for limited funds, is an important policy consideration requiring new thinking and approaches.
In 1971, Omran (1) described how health anddisease patterns change over time in societies,depending, amongother factors, on the degree of
demographic transition and rate of economic de-
velopment, to result in an epidemiological tran-
sition. Like individuals, societies have a “life cycle”:
In a “young” society, infectious diseases and nutri-
tional deficiencies dominate; hence in children,
diarrhea and acute respiratory infections, includ-
ing measles and malaria, predominate; in pregnant
women, fetal loss, perinatal death from undernu-
trition, bleeding, and infection are major risks, and
in the surviving adults, tuberculosis (TB) and other
diseases related to poverty are important causes of
morbidity. When societies “grow up,” accidents
andviolence-related disabilities anddeaths increase,
mostly among the young, and although infectious
diseases such as TB still prevail, chronic noncom-
municable diseases (NCDs) become more preva-
lent, particularly in urban populations. In aging
societies, NCDs predominate: first, type 2 diabetes
and cardiovascular diseases, followed by cancer and
degenerative disorders. Simultaneously, in extreme
cases the broad-based demographic pyramid inverts.
Demographic transition as themain explanation
for the growing NCD burden has, however, been
questioned. Stuckler (2), in a thorough analysis of
causes that was published in the same journal as
Omran’s historical paper, pointed out that partic-
ularly in low-income countries, economic growth,
market integration, foreign direct investment, and
urbanization together correlated threefold greater
to epidemiological transition than did population
aging. The projections of disease burden in Fig. 1
are made by considering the combined effect of
demographical transition (population growth and
increasing life expectancies) and expected impact
of changing lifestyle, living conditions, and eco-
nomic development (3).
Omran (1) has also been criticized for overlook-
ing new epidemics of infectious diseases, but this
author could not have predicted the HIVepidemic,
which disturbed hismodel, set back the epidemiolog-
ical anddemographic transition, and,more important-
ly, reversed the reduction of deaths from infections
in children and young adults, particularly in sub-
Saharan Africa. As a consequence, combating HIV
and other major infections and improving child and
maternal health remained prominent among the
Millennium Development Goals (MDGs) set in
2000. Similarly, the United Nations’ General As-
sembly (UNGASS) in 2001 committed all govern-
ments to combat theHIVepidemic (but notNCDs),
and, consequently, WHO and UNAIDS updated
their “Strategies for the Prevention and Control of
Communicable Diseases” (4). In that document,
NCDs—such as diabetes, as a potential risk factor
for infections, or TB in particular—were not men-
tioned. None of theMDGs relate directly to NCDs,
although Stuckler et al. (5) and others have in-
dicated that MDGs may not be attained without
addressing NCDs as risk or cofactors for commu-
nicable diseases.
Before the turn of the millennium, some re-
searchers (6) and the World Health Organization
(WHO) (7) had pointed at the danger of a “double
burden of disease,” such as the emerging epidemic
of chronic NCDs, in addition to the “unfinished
agenda of infectious diseases” and problems of
maternal and child health. Yach et al. (8) showed
that even in the poorest countries, more deaths are
caused byNCDs than from infections, and that the
WHOHeadquarters spent onlyUS$0.50 on chron-
ic diseases per death per person compared with
US$7.50 for leading communicable diseases.
Yet in 2005, the WHO in its report “Preventing
chronic diseases—A vital investment” (9) under-
scored that NCDs do not only hit the old, the rich,
and the fat; developing countries carry the heaviest
burden of NCDs. In 2007, the World Bank (WB)
issued a similar report on the conceptions, miscon-
ceptions, and challenges presented by chronicNCDs
(10). In 2011, partly as a result of these reports and
provoked by continuous lobbying by civil society
and leading stakeholders in NCDs, including the
InternationalUnionAgainst Cancer, theWorldHeart
Federation, the Global Alliance against Chronic
Respiratory Diseases, the International Diabetes
Federation, and the International Union Against
Tuberculosis and Lung Disease, UNGASS com-
mitted governments to fight the emerging epidemic
of NCDs, acknowledging that NCDs hit develop-
ing countries hard (11). When reading and com-
paring the UNGASS declarations from 2001 and
2011, unfortunately, the known and potential links
between infectious diseases and NCDs are barely
visible. Similarly, in the 182-page 2005 WHO re-
port (9) and the 188-page 2007 WB report (10) on
NCDs, TB is mentioned once in each report, ma-
laria once in the WHO report, and HIV six and
three times, respectively.
A major barrier for integrated intervention
against the double burden of infections and NCDs
may be that their etiologies and pathologies at first
glance appear to be diametrically opposed. As part
of new public management, researchers, health pro-
fessionals, donor agencies, and politicians are often
forced to focus on a particular health problem to get
visible results and fulfill result contracts. At a time of
global financial crises and shrinking health bud-
gets, there is a threat that the battle against common
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and future health problems, both communicable
and noncommunicable, may become a fight for
funds to control either health problem, rather than
a fight against the double burden of disease.
A key question to be answered before setting
priorities and allocating (or reallocating) resources
for health beyond 2015 iswhether the sharp demar-
cation between communicable diseases and NCDs,
which is apparent in most projections of global
mortality and burden of disease—includingWHO’s
in Fig. 1—is justified when both may hit the same
individuals and societies. In the following, I high-
light some potential and verified links between
diseases and discuss possible ways of addressing
them jointly and/or without unnecessary competi-
tion for financial or human resources.
Intensifying interventions against joint risk
factors for NCDs—including diabetes, chronic ob-
structive pulmonary disease, some cancers, and
against a major infectious disease, TB—by fight-
ingmalnutrition (12) and tobacco and alcohol use
is an obvious priority. Preventing common cancers
by vaccinating against the virus that induces them,
including human papilloma virus (HPV) and
hepatitis B (HBV), is another priority.
If NCDs could be prevented by improving ma-
ternal and child health, it would be welcomed by
policy- and decision-makers in low- and middle-
income countries (LMICs). But how much are
NCDs in adults related to ill-health in mothers and
children? Indeed, infection and deficiencies in preg-
nancy, such as malaria and anemia, often result in
fetal and maternal loss, prematurity, and low birth
weight (13), and it is established that undernutrition
and communicable diseases in childhood do inter-
act (14). It is less well known that adverse events in
early life play amajor role in cardiovascular diseases
and diabetes. In the 1980s, Barker and Osmond
(15) found that ischemic heart disease mortality
rates strongly correlated with neonatal and post-
neonatal mortality 50 years earlier. This prompted
Hales and Barker’s “thrifty phenotype theory,”
now confirmed, that low birth weight may induce
early debut of cardiovascular disease and type 2
diabetes (16), as also described byLutter and Lutter
in this issue (17). Thus, intensifying programs to
improve maternal and child health could reduce
risks for NCDs. Aswe have proposed, and present-
ly are investigating inEastAfrica,metabolic disease
in adult life may even be prevented by malaria
control in pregnancy (18).Barker andOsmond (15)
showed that poor nutrition in early life increases
susceptibility to the effects of amore affluent diet in
later life. In many LMICs, a nutritional transition
may take place in a single generation, and it is pos-
sible that induction of insulin resistance by epige-
netic silencing of insulin-regulating genes in utero
could be the mechanism (19). Insulin resistance
induced in early life may be reversible, but if catch-
up growth is too fast, some data point at an in-
creased risk of low-birth-weight children becoming
obese (20). Breast-feeding is strongly recommended
for low-, as well as normal-, birth-weight and large
(macrosomic) babies and protects against diarrhea,
respiratory infections, and obesity (21). Overweight
mothers and high-birth-weight neonates are at high
risk for developing diabetes (22). Promotion of breast
feeding would be a low-cost, low-hanging tool for
the prevention of NCDs, as well as infection (17).
Screening for gestational diabetes could be part
of an integrated, antenatal care program, alongwith
screening for and prevention of malaria, HIV, and
HBV transmission from mother to child. HIV in-
creases the risk for HPV-induced cervical cancer
threefold, and 80%of cervical cancer cases occur in
LMICs (23). Presently, highly effective but costly
vaccination againstHPVismainly available in high-
income countries, althoughvaccination againstHBV
is increasingly becoming part of expanded programs
on immunization, even in LMICs, preventing cir-
rhosis, as well as cancer of the liver.
The HIVepidemic taught us that the risk for de-
velopingTB increasesmore than fourfoldwhere both
diseases are prevalent. In spite of this, it took almost
20 years before the WHO and UNAIDS managed
to agree on guidelines for the implementation of col-
laborative TB and HIV program activities (24). HIV
plus malaria also negatively affect human health;
likewise, it took 20 years to formulate recommenda-
tions on how to fight them jointly (25). Hopefully,
strategies for combating the double burden of com-
municable diseases and NCDs have a shorter incu-
bation time. There are some success stories.
Diabetes’ interaction with TB was recognized
early but later forgotten by clinicians and public
health experts when TB declined in the Western
world. Only when diabetes rose exponentially in
TB-prevalent LMICs were interactions and impli-
cations for control reviewed (26). This review and
other publications documented that the risk for
developing TB increases threefold in diabetics, and
that TB may in turn increase the risk for type 2
diabetes by inducing glucose intolerance and dete-
riorating glycemic control (27). Fortunately, the les-
sons learned from the HIV-associated TB prompted
a much faster reaction to the looming epidemic of
diabetes-associated TB (28). A framework has been
established in less than 5 years to guide national
programs, clinicians, and others engaged in care of
patients on how to establish a coordinated response
to both diseases at organizational and clinical levels.
In China, India, and other countries with high bur-
dens of both diseases, large-scale programs for dual
screening andmanagement are nowbeing rolled out
(29). One example of applying management tools
fromTBdirectly to themanagement of diabetes in a
low-income country is the successful introduction of
“DOTS for Diabetes” in Malawi (30).
AsHalfdanMahler, “the father of primary health
care” stressed back in 1966 (31), when attempting
to convince decision-makers that a double burden
of disease requires integrated control strategies that
should begin in the primary health care sector (32),
it should not be forgotten that “integration, far from
being a laissez-faire approach, requires maximum
involvement of all specialized personnel such as
programmers, organizers, tutors and assessors.”Thus,
when adjusting health systems to meet the chal-
lenges of the double burden of disease, whether
caused by aging or changing living conditions or
both, a multidimensional approach is needed, rang-
ing from education, equity, and economic devel-
opment to environmental change (33).
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PERSPECTIVE
Why a Macroeconomic Perspective
Is Critical to the Prevention of
Noncommunicable Disease
Richard Smith
Effective prevention of noncommunicable diseases will require changes in how we live, and
thereby effect important economic changes across populations, sectors, and countries. What we
do not know is which populations, sectors, or countries will be positively or negatively affected
by such changes, nor by how much. Without this information we cannot know which policies
will produce effects that are beneficial both for economies and for health.
Bill Shankly (manager of Liverpool FootballClub from 1959 to 1974) said football (soc-cer) is “not just a matter of life and death,
it’s more important than that.” For economists, so
are noncommunicable diseases (NCDs) (1). Not
only are the effects of NCDs felt throughout the
economy (Table 1), but since the agents contributing
to NCDs are influenced by our lifestyles, effective
preventive policies are likely to includemechanisms
that themselves have appreciable economic impacts,
such as taxing soft-drinks, increasing the use of
public transport, or promoting lower-polluting ener-
gy sources (2, 3). Although the impacts of such
policies may improve health, there will be substan-
tive economic impacts as they ripple out through
the economy, generating differential effects across
various sectors, such as housing, transport, and ag-
riculture. These economic effects may generate yet
further health effects, which themselves then feed
into the economy, generating yet more cycles of
effects. This interaction and reciprocity between
NCDs and the economy highlights the critical need
for a macroeconomic perspective in the design,
implementation, and evaluation of preventive pol-
icies to tackle NCDs.
Macroeconomics, as compared with microeco-
nomics (which is focused upon “partial equilibrium”
within a single sector, such as for housing or meat),
is concerned with general equilibrium across all
sectors, and thus how changes in one sector (e.g.,
increase in price) affect other sectors, with all these
changes together comprising the overall “economic
impact” of a single change (4, 5). For instance, the
impact of pandemic influenza on the healthcare
sector is minimal compared with its effect on gross
domestic product (GDP) through impacts on other
sectors (e.g., hotels, leisure, travel), which are a
consequence of changes in individual behavior in
response to pandemic threat and the mitigation
policies themselves (6, 7).
Why Is This Important for NCD Prevention?
NCDs, such as diabetes, cancer, and heart disease,
differ from infectious diseases, such as pandemic
influenza, as they are not transmitted from person to
person [although there is evidence emerging in the
social sciences of “social contagion,” where social
networks appear to influence the probability of obe-
sity, for instance (8)]. However, they also differ in
that they are intrinsically lifestyle diseases, and hence
the cause and impact are linked in a multiplicity
of ways to everyday economic activity (Fig. 1).
NCD-related health (Fig. 1, box 1) is deter-
mined directly by risk factors (Fig. 1, box 2),
which include genetic predisposition to disease,
such as diabetes and heart disease, but also by a
range of other social determinants of health, which
refer to the general conditions in which people live
and work, including levels and types of employ-
ment, environmental conditions, and education (9).
These social determinants, contribute to the risk of
different diseases, such as pollution-related diseases
and cancer. They are also intimately linkedwith the
household and individual (Fig. 1, box 3), which
represent how people behave and, crucially, invest
(or disinvest) in their health by what they consume
and in the activities they undertake (8). For exam-
ple, cancer and heart disease riskwill be affected by
decisions concerning smoking, alcohol consump-
tion, and exercise. But riskwill also influence house-
hold and individual behavior. For instance, an
individual’s knowing that they have a higher ge-
netic risk of heart disease may modify individual
consumption of fast food. The healthcare sector
(Fig. 1, box 4) comprises goods and services con-
sumed by households principally to improve health
status. Although these affect NCD-related health
directly, they also impact on the household economy,
which ultimately pays for them through taxation,
insurance, or out-of-pocket. The level of ill-health
caused by NCDs will also feed back and impact on
the household, thus further affecting the risk of other
health problems through reducing household in-
come, and feed into healthcare provision through
shaping the demand for services, and hence profile
of provision (e.g., more insulin prescriptions).
Activity in all non-healthcare sectors in the eco-
nomy (Fig. 1, box 5), such as agriculture, manufac-
turing, and education, impacts on the previous three
components and, thus, NCDs. It is well established,
for instance, that “wealthier is healthier” (10, 11), but
that wealth also brings an increase in NCD risk,
such as through changes in dietary habits, with the
suggestion that in some cases this means that eco-
nomic recessions can have positive health benefits
(12). As countries grow wealthier, their populations
experience increased desirability and availability of
processed foods, perhaps mostly starkly indicated
by the experience of somePacific island populations
where traditional diets have been displaced with
high-fat imported foodstuffs and a concomitant in-
crease in obesity rates and NCDs. Similarly, the
transformation of food retail as countries become
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